Site search
2880 results for '' found
Prophylaxis against early ventilator-associated infections to reduce mortality in mechanically ventilated ICU patients with acute brain injuries (NCT06819592)
Prophylaxis against early ventilator-associated infections to reduce mortality in mechanically ventilated ICU patients with acute brain injuries (NCT06819592)
/
Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated with Pirtobrutinib after Previous Treatment with Zanubrutinib (NCT06812715)
Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated with Pirtobrutinib after Previous Treatment with Zanubrutinib (NCT06812715)
/
PACEmaker AUGMENTed AF ablation in participants with AF and sinus node disease – the PACE AUGMENT-AF Study (ACTRN12625000546459)
PACEmaker AUGMENTed AF ablation in participants with AF and sinus node disease – the PACE AUGMENT-AF Study (ACTRN12625000546459)
/
A Phase 1 Study to Evaluate the Safety of a Novel, In Vivo Gene Therapy to Create Anti-BCMA CAR-T Cells in Patients with Relapsed and Refractory Multiple Myeloma (NCT07075185)
A Phase 1 Study to Evaluate the Safety of a Novel, In Vivo Gene Therapy to Create Anti-BCMA CAR-T Cells in Patients with Relapsed and Refractory Multiple Myeloma (NCT07075185)
/
A Clinical Study of the CorWave® Left Ventricular Assist System For the treatment of patients with advanced heart failure (NCT06907017)
A Clinical Study of the CorWave® Left Ventricular Assist System For the treatment of patients with advanced heart failure (NCT06907017)
/
A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymph
A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymph
/
A Phase 3, Open-Label, Randomized Study of Sonrotoclax [BGB-11417] plus Zanubrutinib [BGB-3111] Compared with Venetoclax plus Acalabrutinib in Patients with Previously Untreated Chronic Lymphocyt
A Phase 3, Open-Label, Randomized Study of Sonrotoclax [BGB-11417] plus Zanubrutinib [BGB-3111] Compared with Venetoclax plus Acalabrutinib in Patients with Previously Untreated Chronic Lymphocyt
/
Are you active in your community and interested in quality healthcare?
Call for Applications for Membership of Bayside Health Community Advisory Committee
/news/are-you-active-in-your-community-and-interested-in-quality-healthcare
Co-Designed_Disability_Awareness_Training_Presentation.pdf
SPEAK_Disability_Data_Systems_Report.pdf